Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 517

1.

Developing an online patient education resource for topical therapy: a pilot study.

Tull TJ, Jackson K, Smith CH, Pink AE.

Br J Dermatol. 2019 Aug 16. doi: 10.1111/bjd.18443. [Epub ahead of print]

PMID:
31420862
2.

Psoriasis biologics: a new era of choice.

Mahil SK, Smith CH.

Lancet. 2019 Aug 8. pii: S0140-6736(19)31772-6. doi: 10.1016/S0140-6736(19)31772-6. [Epub ahead of print] No abstract available.

PMID:
31402113
3.

Morphologic Switch From Psoriasiform to Eczematous Dermatitis After Anti-IL-17 Therapy: A Case Series.

Lai FYX, Higgins E, Smith CH, Barker JN, Pink A.

JAMA Dermatol. 2019 Jul 10. doi: 10.1001/jamadermatol.2019.1268. [Epub ahead of print] No abstract available.

PMID:
31290949
4.

Psoriasis treat to target: defining outcomes in psoriasis using data from a real world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).

Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN, Burden AD, Smith CH; BADBIR study group and the PSORT consortium.

Br J Dermatol. 2019 Jul 8. doi: 10.1111/bjd.18333. [Epub ahead of print]

PMID:
31286471
5.

Prevalence of Advanced Liver Fibrosis in Patients With Severe Psoriasis.

Maybury CM, Porter HF, Kloczko E, Duckworth M, Cotton A, Thornberry K, Dew T, Crook M, Natas S, Miquel R, Lewis CM, Wong T, Smith CH, Barker JN.

JAMA Dermatol. 2019 Jun 5. doi: 10.1001/jamadermatol.2019.0721. [Epub ahead of print]

PMID:
31166567
6.

Helping Patients With Head and Neck Cancer Understand Dysphagia: Exploring the Use of Video-Animation.

Govender R, Taylor SA, Smith CH, Gardner B.

Am J Speech Lang Pathol. 2019 May 27;28(2):697-705. doi: 10.1044/2018_AJSLP-18-0184. Epub 2019 Mar 7.

PMID:
31136243
7.

Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.

Smith CH, Patel S, Woolley RL, Brady MC, Rick CE, Halfpenny R, Rontiris A, Knox-Smith L, Dowling F, Clarke CE, Au P, Ives N, Wheatley K, Sackley CM.

Clin Linguist Phon. 2019 Apr 29:1-8. doi: 10.1080/02699206.2019.1604806. [Epub ahead of print]

PMID:
31035809
8.

Development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series.

Willsmore ZN, Woolf RT, Hughes C, Menon B, Kirkham B, Smith CH, Pink AE.

Br J Dermatol. 2019 Apr 24. doi: 10.1111/bjd.18031. [Epub ahead of print] No abstract available.

PMID:
31017658
9.

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Tziotzios C, Petridis C, Dand N, Ainali C, Saklatvala JR, Pullabhatla V, Onoufriadis A, Pramanik R, Baudry D, Lee SH, Wood K, Liu L, Seegobin S, Michelotti GA, Lwin SM, Christou EAA, Curtis CJ, de Rinaldis E, Saxena A, Holmes S, Harries M, Palamaras I, Cunningham F, Parkins G, Kaur M, Farrant P, McDonagh A, Messenger A, Jones J, Jolliffe V, Ali I, Ardern-Jones M, Mitchell C, Burrows N, Atkar R, Banfield C, Alexandroff A, Champagne C, Cooper HL, Vañó-Galván S, Molina-Ruiz AM, Perez NO, Patel GK, Macbeth A, Page M, Bryden A, Mowbray M, Wahie S, Armstrong K, Cooke N, Goodfield M, Man I, de Berker D, Dunnill G, Takwale A, Rao A, Siah TW, Sinclair R, Wade MS, Dlova NC, Setterfield J, Lewis F, Bhargava K, Kirkpatrick N, Estivill X, Stefanato CM, Flohr C, Spector T, Watt FM, Smith CH, Barker JN, Fenton DA, Simpson MA, McGrath JA.

Nat Commun. 2019 Mar 8;10(1):1150. doi: 10.1038/s41467-019-09117-w.

10.

A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis.

Yiu ZZN, Mason KJ, Barker JNWN, Hampton PJ, McElhone K, Smith CH, Warren RB, Griffiths CEM, Lunt M, Burden AD; BADBIR Study Group.

Br J Dermatol. 2019 Mar 1. doi: 10.1111/bjd.17849. [Epub ahead of print]

11.

Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic.

Mahil SK, McSweeney SM, Kloczko E, McGowan B, Barker JN, Smith CH.

Br J Dermatol. 2019 Feb 6. doi: 10.1111/bjd.17741. [Epub ahead of print]

PMID:
30729517
12.

Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab.

Storan ER, Woolf RT, Smith CH, Pink AE.

Br J Dermatol. 2019 Aug;181(2):385-386. doi: 10.1111/bjd.17712. Epub 2019 Apr 19. No abstract available.

PMID:
30719708
13.

Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic.

Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS.

Front Oncol. 2019 Jan 17;8:652. doi: 10.3389/fonc.2018.00652. eCollection 2018.

14.

Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.

Mu W, Muriello M, Clemens JL, Wang Y, Smith CH, Tran PT, Rowe PC, Francomano CA, Kline AD, Bodurtha J.

Am J Med Genet A. 2019 Apr;179(4):561-569. doi: 10.1002/ajmg.a.61055. Epub 2019 Jan 31.

PMID:
30703284
15.

Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.

Berkhout LC, l'Ami MJ, Ruwaard J, Hart MH, Heer PO, Bloem K, Nurmohamed MT, van Vollenhoven RF, Boers M, Alvarez DF, Smith CH, Wolbink GJ, Rispens T.

Sci Transl Med. 2019 Jan 30;11(477). pii: eaat3356. doi: 10.1126/scitranslmed.aat3356.

PMID:
30700574
16.

Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.

Mason KJ, Williams S, Yiu ZZN, McElhone K, Ashcroft DM, Kleyn CE, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, Griffiths CEM.

Br J Dermatol. 2019 Aug;181(2):256-264. doi: 10.1111/bjd.17625. Epub 2019 Mar 27. Review.

PMID:
30628069
17.

Reply.

Navarini AA, Smith CH, Barker JN, Capon F.

J Allergy Clin Immunol. 2019 Feb;143(2):810-811. doi: 10.1016/j.jaci.2018.11.010. Epub 2019 Jan 1. No abstract available.

PMID:
30606493
18.

HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis.

Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G, Burden AD, Goodwin RG, McKenna K, Murphy R, Perera GK, Rotarescu R, Wahie S, Wright A, Reynolds NJ, Warren RB, Griffiths CEM, Smith CH, Simpson MA, Barker JN; BADBIR Study Group; BSTOP Study Group; PSORT Consortium.

J Allergy Clin Immunol. 2019 Jun;143(6):2120-2130. doi: 10.1016/j.jaci.2018.11.038. Epub 2018 Dec 20.

PMID:
30578879
19.

Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acne.

Petridis C, Navarini AA, Dand N, Saklatvala J, Baudry D, Duckworth M, Allen MH, Curtis CJ, Lee SH, Burden AD, Layton A, Bataille V, Pink AE; Acne Genetic Study Group, Carlavan I, Voegel JJ, Spector TD, Trembath RC, McGrath JA, Smith CH, Barker JN, Simpson MA.

Nat Commun. 2018 Dec 12;9(1):5075. doi: 10.1038/s41467-018-07459-5.

20.

Integrative taxonomy resolves taxonomic uncertainty for freshwater mussels being considered for protection under the U.S. Endangered Species Act.

Johnson NA, Smith CH, Pfeiffer JM, Randklev CR, Williams JD, Austin JD.

Sci Rep. 2018 Oct 26;8(1):15892. doi: 10.1038/s41598-018-33806-z.

21.

Modifying the consistency of food and fluids for swallowing difficulties in dementia.

Flynn E, Smith CH, Walsh CD, Walshe M.

Cochrane Database Syst Rev. 2018 Sep 24;9:CD011077. doi: 10.1002/14651858.CD011077.pub2. Review.

PMID:
30251253
22.

Clinical outcomes in patients on secukinumab (Cosentyx® ) within a specialist psoriasis clinic: a single centre, retrospective cohort study.

Sears AV, Szlumper C, Liu KW, Smith CH, Barker JNWN, Pink AE.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e89-e91. doi: 10.1111/jdv.15245. Epub 2018 Oct 1. No abstract available.

PMID:
30198598
23.

Pain and sleep quality in children with non-vascular Ehlers-Danlos syndromes.

Muriello M, Clemens JL, Mu W, Tran PT, Rowe PC, Smith CH, Francomano C, Bodurtha J, Kline AD.

Am J Med Genet A. 2018 Sep;176(9):1858-1864. doi: 10.1002/ajmg.a.40371. Epub 2018 Sep 4.

24.

Aldara-induced dermatitis is associated with development of liver fibrosis in mice.

Maybury CM, Di Meglio P, Smith CH.

Br J Dermatol. 2018 Jul;179(1):9-10. doi: 10.1111/bjd.16693. No abstract available.

PMID:
30156283
25.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2019 Feb;180(2):329-337. doi: 10.1111/bjd.17036. Epub 2018 Oct 21.

PMID:
30070708
26.

Clinical and genetic differences between pustular psoriasis subtypes.

Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F.

J Allergy Clin Immunol. 2019 Mar;143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21.

28.

Atopic dermatitis: the skin barrier and beyond.

Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C.

Br J Dermatol. 2019 Mar;180(3):464-474. doi: 10.1111/bjd.16934. Epub 2018 Oct 10. Review.

PMID:
29969827
29.

Molecular and morphological data to facilitate future research on freshwater mussels (Bivalvia: Unionidae: Anodontinae).

Smith CH, Johnson NA, Pfeiffer JM, Gangloff MM.

Data Brief. 2018 Jan 3;17:95-104. doi: 10.1016/j.dib.2017.12.050. eCollection 2018 Apr.

30.

Fabrication of microstructured binary polymer brush "corrals" with integral pH sensing for studies of proton transport in model membrane systems.

Madsen J, Ducker RE, Al Jaf O, Cartron ML, Alswieleh AM, Smith CH, Hunter CN, Armes SP, Leggett GJ.

Chem Sci. 2018 Jan 15;9(8):2238-2251. doi: 10.1039/c7sc04424k. eCollection 2018 Feb 28.

31.

Palliative Care and Hospice Interventions in Decompensated Cirrhosis and Hepatocellular Carcinoma: A Rapid Review of Literature.

Mudumbi SK, Bourgeois CE, Hoppman NA, Smith CH, Verma M, Bakitas MA, Brown CJ, Markland AD.

J Palliat Med. 2018 Aug;21(8):1177-1184. doi: 10.1089/jpm.2017.0656. Epub 2018 Apr 26.

32.

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR.

Mason KJ, Barker JNWN, Smith CH, Hampton PJ, Lunt M, McElhone K, Warren RB, Yiu ZZN, Griffiths CEM, Burden AD; BADBIR Study Group.

JAMA Dermatol. 2018 May 1;154(5):581-588. doi: 10.1001/jamadermatol.2018.0183.

33.

Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal.

Tsakok T, Jabbar-Lopez ZK, Smith CH.

Br J Dermatol. 2018 Jul;179(1):50-53. doi: 10.1111/bjd.16424. Epub 2018 May 9.

PMID:
29399784
34.

Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot).

Sackley CM, Smith CH, Rick CE, Brady MC, Ives N, Patel S, Woolley R, Dowling F, Patel R, Roberts H, Jowett S, Wheatley K, Kelly D, Sands G, Clarke CE; PD COMM Pilot Collaborative Group.

Pilot Feasibility Stud. 2018 Jan 10;4:30. doi: 10.1186/s40814-017-0222-z. eCollection 2018.

35.

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).

de Bruin-Weller M, Thaçi D, Smith CH, Reich K, Cork MJ, Radin A, Zhang Q, Akinlade B, Gadkari A, Eckert L, Hultsch T, Chen Z, Pirozzi G, Graham NMH, Shumel B.

Br J Dermatol. 2018 May;178(5):1083-1101. doi: 10.1111/bjd.16156. Epub 2018 Mar 25.

36.

Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith CH, McHugh N; PROMPT study group.

Ann Rheum Dis. 2018 Feb;77(2):277-280. doi: 10.1136/annrheumdis-2017-212328. Epub 2017 Nov 1.

PMID:
29092855
37.

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Iskandar IYK, Warren RB, Lunt M, Mason KJ, Evans I, McElhone K, Smith CH, Reynolds NJ, Ashcroft DM, Griffiths CEM; BADBIR Study Group.

J Invest Dermatol. 2018 Apr;138(4):775-784. doi: 10.1016/j.jid.2017.09.044. Epub 2017 Dec 6.

38.

Molecular and morphological data reveal non-monophyly and speciation in imperiled freshwater mussels (Anodontoides and Strophitus).

Smith CH, Johnson NA, Pfeiffer JM, Gangloff MM.

Mol Phylogenet Evol. 2018 Feb;119:50-62. doi: 10.1016/j.ympev.2017.10.018. Epub 2017 Oct 23.

PMID:
29074460
39.

Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Smith CH, Ashcroft DM, Lunt M, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

J Invest Dermatol. 2018 Mar;138(3):534-541. doi: 10.1016/j.jid.2017.10.005. Epub 2017 Oct 17.

40.

An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target.

Mahil SK, Catapano M, Di Meglio P, Dand N, Ahlfors H, Carr IM, Smith CH, Trembath RC, Peakman M, Wright J, Ciccarelli FD, Barker JN, Capon F.

Sci Transl Med. 2017 Oct 11;9(411). pii: eaan2514. doi: 10.1126/scitranslmed.aan2514. Erratum in: Sci Transl Med. 2017 Dec 13;9(420):.

41.

Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling.

Dand N, Mucha S, Tsoi LC, Mahil SK, Stuart PE, Arnold A, Baurecht H, Burden AD, Callis Duffin K, Chandran V, Curtis CJ, Das S, Ellinghaus D, Ellinghaus E, Enerback C, Esko T, Gladman DD, Griffiths CEM, Gudjonsson JE, Hoffman P, Homuth G, Hüffmeier U, Krueger GG, Laudes M, Lee SH, Lieb W, Lim HW, Löhr S, Mrowietz U, Müller-Nurayid M, Nöthen M, Peters A, Rahman P, Reis A, Reynolds NJ, Rodriguez E, Schmidt CO, Spain SL, Strauch K, Tejasvi T, Voorhees JJ, Warren RB, Weichenthal M, Weidinger S, Zawistowski M, Nair RP, Capon F, Smith CH, Trembath RC, Abecasis GR, Elder JT, Franke A, Simpson MA, Barker JN.

Hum Mol Genet. 2017 Nov 1;26(21):4301-4313. doi: 10.1093/hmg/ddx328.

42.

European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

Nast A, Spuls PI, van der Kraaij G, Gisondi P, Paul C, Ormerod AD, Saiag P, Smith CH, Dauden E, de Jong EM, Feist E, Jobling R, Maccarone M, Mrowietz U, Papp KA, Reich K, Rosumeck S, Talme T, Thio HB, van de Kerkhof P, Werner RN, Dressler C.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):1951-1963. doi: 10.1111/jdv.14454. Epub 2017 Sep 11. No abstract available.

PMID:
28895202
43.

Re: Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.

Jabbar-Lopez ZK, Yiu ZZN, Ward V, Exton LS, Mohd Mustapa MF, Samarasekera E, Burden AD, Murphy R, Owen CM, Parslew R, Venning V, Warren RB, Smith CH.

J Invest Dermatol. 2017 Dec;137(12):2644-2646. doi: 10.1016/j.jid.2017.07.848. Epub 2017 Aug 31. No abstract available.

44.

The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease.

Masterson-Algar P, Burton CR, Brady MC, Nicoll A, Clarke CE, Rick C, Hughes M, Au P, Smith CH, Sackley CM.

Trials. 2017 Aug 29;18(1):397. doi: 10.1186/s13063-017-2130-1.

45.

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.

Bowes J, Ashcroft J, Dand N, Jalali-Najafabadi F, Bellou E, Ho P, Marzo-Ortega H, Helliwell PS, Feletar M, Ryan AW, Kane DJ, Korendowych E, Simpson MA, Packham J, McManus R, Brown MA, Smith CH, Barker JN, McHugh N, FitzGerald O, Warren RB, Barton A.

Ann Rheum Dis. 2017 Oct;76(10):1774-1779. doi: 10.1136/annrheumdis-2017-211414. Epub 2017 Aug 18.

46.

Obesity, Waist Circumference, Weight Change, and Risk of Incident Psoriasis: Prospective Data from the HUNT Study.

Snekvik I, Smith CH, Nilsen TIL, Langan SM, Modalsli EH, Romundstad PR, Saunes M.

J Invest Dermatol. 2017 Dec;137(12):2484-2490. doi: 10.1016/j.jid.2017.07.822. Epub 2017 Aug 2.

47.

Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic.

Momen SE, Kirkham B, Barker JN, Smith CH.

Br J Dermatol. 2017 Dec;177(6):1519-1526. doi: 10.1111/bjd.15866. Epub 2017 Dec 11. Review. No abstract available.

PMID:
28771665
48.

Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.

Pink AE, Smith CH.

Br J Dermatol. 2017 Jul;177(1):7-8. doi: 10.1111/bjd.15645. No abstract available.

PMID:
28731243
49.

Risk of cancer in patients with psoriasis on biological therapies: a systematic review.

Peleva E, Exton LS, Kelley K, Kleyn CE, Mason KJ, Smith CH.

Br J Dermatol. 2018 Jan;178(1):103-113. doi: 10.1111/bjd.15830. Epub 2017 Dec 18.

PMID:
28722163
50.

Exposure to biological therapies during conception and pregnancy: a systematic review.

Pottinger E, Woolf RT, Exton LS, Burden AD, Nelson-Piercy C, Smith CH.

Br J Dermatol. 2018 Jan;178(1):95-102. doi: 10.1111/bjd.15802. Epub 2017 Dec 14.

PMID:
28718898

Supplemental Content

Loading ...
Support Center